Cargando…
2436. Real-world Evidence of Fecal Microbiota Transplant Use and Outcomes in Patients with Clostridioides difficile Infection
BACKGROUND: Clostridioides difficile infection (CDI) and recurrent CDI (rCDI) are associated with substantial economic burden, quality-of-life impairment, and increased morbidity and mortality. Fecal microbiota transplant (FMT) is an investigational, non-antibiotic approach to attempt to prevent rec...
Autores principales: | Nelson, Winnie, Lau, Merwin, Kloss, Stefan, Grace Tucker, Sarah, Stong, Laura, Dahdal, David N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810382/ http://dx.doi.org/10.1093/ofid/ofz360.2114 |
Ejemplares similares
-
Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis
por: Feuerstadt, Paul, et al.
Publicado: (2021) -
2374. Healthcare Resource Use, Costs, and Recurrences in Patients with Clostridioides difficile Infection: A Real-world Data Analysis
por: Nelson, Winnie, et al.
Publicado: (2019) -
Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021) -
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023) -
Clinical burden of recurrent Clostridioides difficile infection in the medicare population: A real-world claims analysis
por: Feuerstadt, Paul, et al.
Publicado: (2022)